119 related articles for article (PubMed ID: 25001535)
1. Cancer-selective apoptosis by tumor suppressor par-4.
Hebbar N; Shrestha-Bhattarai T; Rangnekar VM
Adv Exp Med Biol; 2014; 818():155-66. PubMed ID: 25001535
[TBL] [Abstract][Full Text] [Related]
2. Cancer-selective apoptotic effects of extracellular and intracellular Par-4.
Shrestha-Bhattarai T; Rangnekar VM
Oncogene; 2010 Jul; 29(27):3873-80. PubMed ID: 20440265
[TBL] [Abstract][Full Text] [Related]
3. Systemic Par-4 inhibits non-autochthonous tumor growth.
Zhao Y; Burikhanov R; Brandon J; Qiu S; Shelton BJ; Spear B; Bondada S; Bryson S; Rangnekar VM
Cancer Biol Ther; 2011 Jul; 12(2):152-7. PubMed ID: 21613819
[TBL] [Abstract][Full Text] [Related]
4. Role of PAR-4 in ovarian cancer.
Meynier S; Kramer M; Ribaux P; Tille JC; Delie F; Petignat P; Cohen M
Oncotarget; 2015 Sep; 6(26):22641-52. PubMed ID: 26246468
[TBL] [Abstract][Full Text] [Related]
5. The Role of Prostate Apoptosis Response-4 (Par-4) in Mycobacterium tuberculosis Infected Macrophages.
Han JY; Lim YJ; Choi JA; Lee JH; Jo SH; Oh SM; Song CH
Sci Rep; 2016 Aug; 6():32079. PubMed ID: 27552917
[TBL] [Abstract][Full Text] [Related]
6. [Pro-apoptosis and selective anticancer activities of prostate apoptosis response protein 4: research progress and prospects].
Wu Z; Wang G; Zhang K
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jan; 34(1):128-32. PubMed ID: 24463134
[TBL] [Abstract][Full Text] [Related]
7. Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4.
Burikhanov R; Shrestha-Bhattarai T; Qiu S; Shukla N; Hebbar N; Lele SM; Horbinski C; Rangnekar VM
Cancer Res; 2013 Jan; 73(2):1011-9. PubMed ID: 23204231
[TBL] [Abstract][Full Text] [Related]
8. [Pdcd4 tumor suppressor: properties, functions, and their application to oncology].
Vikhreva PN; Shepelev MV; Korobko EV; Korobko IV
Mol Gen Mikrobiol Virusol; 2010; (2):3-11. PubMed ID: 20545042
[TBL] [Abstract][Full Text] [Related]
9. Par-4 as a potential target for cancer therapy.
Irby RB; Kline CL
Expert Opin Ther Targets; 2013 Jan; 17(1):77-87. PubMed ID: 23062118
[TBL] [Abstract][Full Text] [Related]
10. Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner.
Amantini C; Ballarini P; Caprodossi S; Nabissi M; Morelli MB; Lucciarini R; Cardarelli MA; Mammana G; Santoni G
Carcinogenesis; 2009 Aug; 30(8):1320-9. PubMed ID: 19502594
[TBL] [Abstract][Full Text] [Related]
11. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.
Kline CL; Irby RB
Apoptosis; 2011 Dec; 16(12):1285-94. PubMed ID: 21910008
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cancer cell survival by Par-4.
Ranganathan P; Rangnekar VM
Ann N Y Acad Sci; 2005 Nov; 1059():76-85. PubMed ID: 16382046
[TBL] [Abstract][Full Text] [Related]
13. Involvement of extrinsic and intrinsic apoptotic pathways together with endoplasmic reticulum stress in cell death induced by naphthylchalcones in a leukemic cell line: advantages of multi-target action.
Winter E; Chiaradia LD; Silva AH; Nunes RJ; Yunes RA; Creczynski-Pasa TB
Toxicol In Vitro; 2014 Aug; 28(5):769-77. PubMed ID: 24583196
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis.
Burikhanov R; Zhao Y; Goswami A; Qiu S; Schwarze SR; Rangnekar VM
Cell; 2009 Jul; 138(2):377-88. PubMed ID: 19632185
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis by Par-4 in cancer and neurodegenerative diseases.
El-Guendy N; Rangnekar VM
Exp Cell Res; 2003 Feb; 283(1):51-66. PubMed ID: 12565819
[TBL] [Abstract][Full Text] [Related]
16. The phosphoinositide 3-kinase/Akt1/Par-4 axis: a cancer-selective therapeutic target.
Goswami A; Ranganathan P; Rangnekar VM
Cancer Res; 2006 Mar; 66(6):2889-92. PubMed ID: 16540633
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK
J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709
[TBL] [Abstract][Full Text] [Related]
18. A novel approach to cancer treatment using structural hybrids of the p53 gene family.
Sasaki Y; Oshima Y; Koyama R; Tamura M; Kashima L; Idogawa M; Yamashita T; Toyota M; Imai K; Shinomura Y; Tokino T
Cancer Gene Ther; 2012 Nov; 19(11):749-56. PubMed ID: 22956039
[TBL] [Abstract][Full Text] [Related]
19. Ectopic expression of Par-4 leads to induction of apoptosis in CNS tumor cell lines.
Vetterkind S; Boosen M; Scheidtmann KH; Preuss U
Int J Oncol; 2005 Jan; 26(1):159-67. PubMed ID: 15586236
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of pro-apoptotic Par-4 by NF-kappaB/p65 and its function in controlling cell kinetics during early events in endometrial tumourigenesis.
Saegusa M; Hashimura M; Kuwata T; Okayasu I
J Pathol; 2010 May; 221(1):26-36. PubMed ID: 20186924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
